Christopher S. Saigal
Overview
Biography
Christopher S. Saigal is a natural scientist at the RAND Corporation and an associate professor in the Department of Urology at the UCLA School of Medicine. His research has focused on quality of care, shared decisionmaking, practice patterns, and costs of care. He is the principal investigator within RAND Health for the Urologic Diseases in America project, a 12-million dollar National Institutes of Health–funded effort to document the burden of illness, patterns of care, and technology trends related to urologic diseases in the United States. Saigal also leads a National Cancer Institute–funded study examining new methods of patient preference elicitation in an effort to improve medical decision analysis and cost-effectiveness analysis. He is active in health policy; after serving as the American Urological Association (AUA) Gallagher Health Policy Scholar, he was asked to represent the AUA at the Ambulatory Quality Alliance and Surgical Quality Alliance and to be the AUA representative to the American College of Surgeons' Surgeon-Specific Registry project. His clinical practice focuses on urologic oncology. He received his M.P.H. from the UCLA School of Public Health and his M.D. from the UCLA School of Medicine.
Research Focus
Concurrent Non-RAND Positions
Associate Professor, Department of Urology, UCLA School of MedicineRecent Projects
- Documenting practice patterns and opportunities for quality improvement in urology
- Policy work regarding pay-for-performance initiatives
Selected Publications
Christopher S. Saigal et al., "Economic Evaluation of Treatment Strategies for Benign Prostatic Hyperplasia- Is Medical Therapy More Costly in the Long Run?" Journal of Urology, 177(4), 2007
Christopher S. Saigal et al., "Predictors and Prevalence of Erectile Dysfunction in a Racially Diverse Population," Archives of Internal Medicine, 166(2), 2006
Christopher S. Saigal et al., "Direct and Indirect Costs of Nephrolithiasis in an Employed Population: Opportunity for Disease Management?" Kidney International, 68(4), 2005
Christopher S. Saigal and Geoffrey Joyce, "Economic Costs of Benign Prostatic Hyperplasia in the Private Sector," Journal of Urology, 173(4), 2005
C. Saigal et al., "Androgen Deprivation Therapy Increases Cardiovascular Morbidity in Men With Prosate Cancer," Cancer
